Skip to product information
1 of 1

Elabscience

SKU:PKSH033517

Recombinant Human STING/TMEM173 Protein (Sumo & His Tag)

Recombinant Human STING/TMEM173 Protein (Sumo & His Tag)

Regular price $275.00 USD
Regular price Sale price $275.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human STC2 (Stanniocalcin-2) Protein, His Tag, a cutting-edge biotechnological product meticulously developed by Dana Biosciences. This protein, encoded by the STC2 gene, is a member of the stanniocalcin family and plays a crucial role in various physiological processes.

Crafted with utmost precision, the Recombinant Human STC2 Protein is produced using advanced recombinant DNA technology, ensuring exceptional purity and bioactivity. The inclusion of a His tag facilitates easy purification and subsequent downstream applications.

This high-quality protein exhibits remarkable stability and solubility, making it an ideal choice for a wide range of research applications. Its versatility enables investigations into the intricate mechanisms underlying cellular processes, including cell proliferation, apoptosis, and differentiation.

The Recombinant Human STC2 Protein, His Tag, is meticulously characterized through rigorous quality control measures, guaranteeing its reliability and reproducibility. Each batch is subjected to meticulous testing to ensure optimal performance, adhering to the highest industry standards.

Researchers and scientists alike will appreciate the convenience and efficiency offered by this product. Its user-friendly nature allows for seamless integration into various experimental setups, facilitating groundbreaking discoveries and advancements in the field of life sciences.

Dana Biosciences, renowned for its commitment to excellence, presents the Recombinant Human STC2 Protein, His Tag, as an invaluable tool for elucidating the intricate mechanisms governing cellular processes. Embark on a journey of scientific exploration and innovation with this exceptional biotechnological offering.
View full details